NCT01178073 · Interventional trial
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
Overall registry status Completed
Phase 3
Conditions Hypertension, Pulmonary
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory